WE@HealthTech
Lindsay Tauber is a seasoned professional in the healthcare and technology sectors, currently serving as the Director of Product at RxWare since October 2017, where leadership involves the execution of tools for patient access to specialty treatments. With a robust background in digital health and operations from Novartis, Lindsay contributed to innovative solutions and played a key role in building a startup culture within the organization. Experience also includes co-founding a nonprofit focused on Israeli art and a decade-long consultancy that advised various clients on communication strategies. Education includes an MBA in Healthcare Innovation from Reichman University and advanced degrees in Jewish Philosophy and Education, alongside a BA from Columbia University. Active membership in WE@HealthTech further demonstrates dedication to advancing women in the HealthTech field.
This person is not in the org chart
WE@HealthTech
Women comprise about 70% of the HealthTech industry work force. Out of the 30 companies listed in the Biomed Index there are only two women CEOs amongst a total of sixty CEOs and Chairmen. The share value of companies that include women on their boards are higher by an average of 44% (Goldman Sachs). FORTUNE 500 companies with a larger number of women in senior management positions have better financial results (Catalyst). It follows that proper representation of women in top managerial levels will serve not only social and gender equality goals, but also organizational, business, and economic goals and performance. In partnership with 8400 we introduce a HealthTech launchpad program to promote junior women managers to executive positions throughout the ecosystem.